Category Archives: Prostate

The Numbers behind the ProtecT Trial

This week’s release of the first study comparing outcomes between surgery, radiation, and active surveillance got a lot of buzz. But even then, some pretty important details did not get as much coverage as they probably could, and maybe even … Continue reading

Posted in Communications, Prostate, Research, Treatment | 1 Comment

New study compares surgery, radiation, and active surveillance in prostate cancer

A long-awaited study from researchers in the United Kingdom compares three major approaches: surgery (radical prostatectomy), radiation, and active surveillance (also known as ‘watchful waiting’) for men with localized prostate cancer diagnosed with prostate specific antigen (PSA) blood test, and … Continue reading

Posted in Prostate, Research, Screening | 2 Comments

Physicians’ Group Releases Prostate Screening Recommendations

New prostate screening recommendations from the American College of Physicians (ACP) released today say men between the ages of 50 and 69 should discuss the limited benefits and substantial harms of the prostate-specific antigen (PSA) test with their doctor before … Continue reading

Posted in Prostate, Screening | Leave a comment

Researchers Link Higher Prostate Cancer Rates to Countries with More Oral Contraceptive Use

A new study appearing in BMJ Open compared rates of prostate cancer in dozens of countries worldwide with oral contraceptive use and finds countries with more use of oral contraceptives have higher rates of prostate cancer incidence and mortality. The … Continue reading

Posted in Environment, Prostate, Research, Uncategorized | Leave a comment

U.S.Panel Says “No” to PSA Screening

Dr. Len Lichtenfeld’s blog is having technical issues, so we are happily hosting his latest post here. –djs By: Len Lichtenfeld, M.D., Deputy Chief Medical Officer, American Cancer Society To screen or not to screen for prostate cancer, that is the question. … Continue reading

Posted in Prostate, Research, Screening, Uncategorized | 6 Comments

Androgen-Deprivation Therapy in Prostate Cancer

The U.S. Food and Drug Administration (FDA) says it is evaluating whether Gonadotropin-Releasing Hormone (GnRH) Agonists may increase the risk of diabetes and certain cardiovascular diseases (heart attack, sudden cardiac death, stroke) in men taking the drugs to treat prostate … Continue reading

Posted in Prostate | Tagged , , | Leave a comment